VIVE is dedicated to empowering kidney health through innovative preventative technology and personalized care
Join VIVE today for early access, product demos, and smarter tools to protect your kidney health.
Dehydration causes concentrated urine, which encourages kidney crystal and stone formation, increasing the risk of kidney damage and chronic kidney disease (CKD). Kidney disease progresses quietly and is often diagnosed late, leading to irreversible damage.
Each year, around 1.3 million people in the U.S. visit emergency departments due to kidney stones, that’s about 3,600 visits daily. About 20% of these visits require hospitalization, and nearly 70% of hospitalized patients undergo at least one surgical procedure.
A hardware device worn continuously to monitor hydration status and body parameters in real-time.
Sends real-time alerts to remind the user to hydrate, helping prevent acute kidney injury episodes.
Physicians send diagnostic testing kits to patients for early detection of kidney injury and stone risk.
Helps assess biomarker levels to guide actions needed to prevent new kidney stone formation.
Cloud-based AI platform integrates data from sensors and test kits to generate personalized kidney risk scores.
Provides tailored hydration and dietary recommendations, including an organized list of foods and drinks to avoid (e.g., high oxalate or kidney stone-forming).
Sends reminders to physicians to timely dispatch urine test kits and nudges patients to follow up.
Mobile app delivers real-time hydration tracking, alerts, and personalized kidney-friendly dietary guidance to patients.
Enables secure sharing of clinical data to support care coordination and proactive management by healthcare providers.
Number of Americans with CKD:
Approximately 37 million adults (1 in 7 Americans or about 15% of the adult population) are estimated to have chronic kidney disease.
Number of Americans with kidney failure (ESRD):
More than 800,000 Americans currently live with end-stage renal disease (ESRD) requiring dialysis or transplant.
Dialysis population:
Nearly 555,000 Americans are on dialysis treatments to sustain life.
Kidney transplants:
Over 260,000 Americans have received kidney transplants, but the waiting list is very long, with about 90,000 people waiting in 2024.
New diagnoses each year:
Every year, about 131,000 Americans are newly diagnosed with kidney failure or ESRD.
Awareness gap:
About 90% of people with CKD do not know they have it, highlighting the critical need for early detection and preventive care.
Cost impact:
Medicare spending on CKD patients ages 66+ was nearly $77 billion in 2021, representing 24.1% of Medicare spending in that age group.
VIVE is dedicated to empowering kidney health through innovative preventative technology and personalized care. Our name comes from the French word meaning “to live” or “long life,” reflecting our mission to help people thrive and live healthier lives. We offer a comprehensive platform combining real-time hydration monitoring, early detection testing, and AI-driven insights to prevent kidney disease before it progresses. At VIVE, we believe in proactive management and smart solutions to protect kidney health and improve quality of life.
We are committed to a bold vision: using AI-powered enabled sensors to advance kidney disease prevention.
To bring this vision to life, we are seeking mission-aligned partners, and investors who share our belief in the power of community and technology to transform lives.